🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.–Irish Trade Implications AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones Using LLMs Safely in Pharma: The Employee Guide to Risk Mitigation, Ethics, and GxP Compliance US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position US Biopharma Group Pfanstiehl Acquires Nestlé’s Former Askeaton Infant Formula Site in Landmark Mid-West Industrial Transition ChatGPT Maker OpenAI Selects Dublin Docklands for New European HQ Expansion After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.–Irish Trade Implications AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones Using LLMs Safely in Pharma: The Employee Guide to Risk Mitigation, Ethics, and GxP Compliance US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position US Biopharma Group Pfanstiehl Acquires Nestlé’s Former Askeaton Infant Formula Site in Landmark Mid-West Industrial Transition ChatGPT Maker OpenAI Selects Dublin Docklands for New European HQ Expansion After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA
Ireland CDMO Directory · Craigavon, Co. Armagh

Almac Group Craigavon

Peptide Synthesis & Commercial Drug Product

Thousands of staff (NI's largest indigenous life sciences employer)
Employees
Global HQ Campus
Facility
Armagh
County
4
Certifications

Facility Overview

Opened a £65M, 100,000 sq ft commercial manufacturing facility in March 2025 for oral dose and potent drug products, alongside a separate 28,000 sq ft GMP peptide API synthesis plant (completed 2024) supporting growing demand for peptide therapeutics.

£65M commercial facility (2025) plus 28,000 sq ft peptide synthesis plant (2024)

Capabilities

Peptide API Manufacturing Commercial Drug Product Clinical Trial Supply Sachet Formulation Drug Discovery

Certifications & Regulatory Licenses

FDA Approved EMA (EU GMP) MHRA ISO 9001
Sourcing & Facility Audit

Considering Almac Group Craigavon for your shortlist?

Tell us your molecule type, dosage form, batch size, and target markets. We coordinate a direct introduction and independent facility assessment.

Request Sourcing & Audit →